likely mediate the antimicrobial functions of mammalian Under normal conditions, mammalian platelets circulate in platelets. the bloodstream as senescent cells that do not interact with vascular endothelium or leukocytes. Platelets possess a sensitive and diverse array of constitutive and inducible membrane receptors that are highly responsive to a broad spectrum of Platelets Are Specialized Inflammatory Cells agonists associated with tissue injury or inflammation. Upon
In many invertebrates, hemocytes serve as multipurpose inactivation, platelets become amoeboid cells that exhibit inducflammatory cells. These cells function to limit the loss of hemoible receptors mediating the increased adhesiveness of these lymph following tissue injury, to internalize microorganisms cells to a variety of tissues. In this regard, platelets have long colonizing wounds, and to initiate the process of wound repair been recognized for their importance in maintaining hemostasis [1, 2] . In higher organisms, thrombocytes and leukocytes have and for their contribution to wound healing. However, platelets been viewed to mediate hemostasis and inflammation, respechave historically been underappreciated for their contributions tively [3, 4] . Mammalian platelets represent further specializato antimicrobial host defense.
tion; arguably, one of their principal roles is the maintenance Platelets exhibit hallmark structural and functional characterof hemostasis. Nonetheless, platelets have retained features of istics that are associated with their participation in host defense inflammatory cells that correspond to their function in antimiagainst infection. For example, platelets rapidly respond to crobial host defense. agonists associated with vascular trauma or infection and accuMammalian platelets are small (2-4 mm), short-lived discoid mulate at sites of endovascular damage or microbial colonizacells that originate from megakaryocyte lineage [5] [6] [7] [8] [9] . Lacking tion. Activation of platelets by agonists generated in these setnuclei, young platelets perform only limited translation with use tings enhances platelet interactions with complement proteins of residual megakaryocyte mRNA templates [10] [11] [12] . Platelets and humoral immune components, as well as leukocytes and contain three distinct cytoplasmic granule types (figure 1). Dense endothelial cells. Likewise, molecules generated by activated (d) granules store mediators of vascular tone including serotonin, endothelial cells and leukocytes enhance platelet antimicrobial adenosine nucleotide diphosphate (ADP), eicosanoids, thromboxresponses.
ane A 2 (TXA 2 ), calcium, and phosphate [3, 5, [13] [14] [15] . In contrast, Platelets are capable of binding, aggregating, and internaliza granules contain proteins involved in hemostatic functions such ing microorganisms, which enhances the clearance of pathoas adhesion (e.g., fibrinogen, thrombospondin, vitronectin, lamigens from the bloodstream. Platelets participate in antibodynin, and von Willebrand factor), modulation of coagulation (e.g., dependent cell cytotoxicity functions to kill protozoal plasminogen, a 2 -plasmin inhibitor, and thrombasthenin), and enpathogens. When stimulated by microorganisms or agonists dothelial cell repair (e.g., platelet-derived growth factor, permegenerated in the setting of infection, platelets release an array ability factor, and transforming growth factors a and b [TGF-a of potent antimicrobial peptides. On the basis of these observaand TGF-b]; [3, 14, 15] ). As will be described in detail below, tions, platelets are presently believed to significantly contribute a granules also likely contain an arsenal of microbicidal proteins to antimicrobial host defense. The following discussion will found in mammalian platelets. Lysosomal (l) granules are befocus on the in vitro and in vivo properties and activities that lieved to contain enzymes that principally mediate thrombus dissolution [3, 5, 14] . These distinct platelet granules are subject to discrete or synchronous release, dependent on agonist specificity and potency. , various eicosanoids, thromboxane A 2 [TXA 2 ], and platelet activating factor [PAF] ); lysosomal (l) granules (contents, e.g., lysozyme and kininogen); and alpha (a) granules (contents, e.g., fibrinogen, thrombospondin, laminin, vitronectin, von Willebrand factor, platelet-derived growth factor, and transforming growth factor [TGF-a and TGF-b]). Also shown are predominant constitutive receptors for platelet agonists, including PAF; ADP; thrombin (Thr); collagen (Col); epinephrine (Epi); and TXA 2 . (B) Activated platelet, illustrating changes in platelet shape, pseudopod formation, granule centralization, and expression of inducible ligands such as P-selectin (GMP-140; ligand for neutrophil adhesion) and receptors such as GPIIb-IIIa (fibrinogen receptor) and von Willebrand factor (vWF) receptor.
Platelets Respond Rapidly to Endothelium Damaged by Platelets Are Present in Infected Endovascular Lesions Trauma or Microbial Colonization
Platelets are the earliest and most abundant cells present at vascular sites of trauma or in the setting of infections involving Vascular injury, alteration of endovascular surfaces, and substantial changes in vascular tone may each prompt platelet the vascular endothelium [25 -35] . Endovascular infections include infective endocarditis, suppurative thrombophlebitis, myresponse. Platelets express specific receptors for agonists and ligands associated with activated endothelial cells or exposed cotic aneurysm, septic endarteritis, catheter and dialysis accesssite infections, and infections of vascular prostheses and stents subendothelial stroma resulting from injury or infection (table 1) (figure 1). Ligands recognized by platelet membrane glyco- [31, 35] . The presence of platelets on artificial surfaces at these sites has also been well established. Osler made perhaps the protein (GP) receptors include collagen (GPIa-IIa or VLA-2), fibronectin (GPIc-IIa or VLA-5), von Willebrand factor (GPIbearliest observations of platelets rapidly coating filaments placed in animal veins [36] . More recently, Cheung and IX), laminin (GPIc'-IIa or VLA-6), vitronectin (a V b 3 integrin [18]), and the peptide receptor for thrombin [14] . Contact with Fischetti [37] and others [30, 35] have shown that platelets are the first cells to interact with indwelling vascular catheters. blood prompts the subendothelial stroma to release thromboplastin (tissue factor [3, 19 -21] ). Tissue factor facilitates an Furthermore, platelets rapidly deposit on cardiac valve prostheses and endovascular stents [35] . ensuing cascade of proteolytic reactions associated with the intrinsic coagulation pathway, ultimately leading to thrombin Durack [26] , Durack et al. [28] , Scheld et al. [25] , Calderone et al. [27] , and Roberts and Buchbinder [33] have demonstrated generation [3, 19 -21] . Thrombin is among the most potent of all platelet agonists [14, 18] (figure 2).
that platelets are the earliest and numerically predominant cells in endocarditis vegetations in rabbits and humans. Thus, platelets are Many platelet receptors, such as platelet membrane integrin fibrinogen receptor (GPIIb-IIIa), as well as P-selectin (gmpknown to rapidly target foreign surfaces as well as sites of vascular endothelium that have been damaged or colonized by microorgan-140), are expressed following platelet activation [3, 14, 18] . In addition, activated platelets undergo a rapid shape change from isms. However, although platelets have indisputable antimicrobial properties (outlined below), their precise role in these settings is discoid to ameoboid and exhibit simultaneous microtubule assembly and granule organization (figure 1) [22, 23] . Degranulamultifactorial and has been subject to interpretation. The conventional view of the natural history of endovascular tion may then occur, releasing, among other agonists, ADP from dense granules and generating TXA 2 and platelet activatinfection, particularly that due to virulent pathogens such as Staphylococcus aureus, generally includes: (1) adherence of hematogeing factor (PAF) through activation of membrane phospholipase A 2 [3, 14 -16]. These particular agonists activate addinous pathogens to normal or predisposed vascular endothelial surfaces (e.g., to those damaged by rheumatic heart disease or to tional platelets at sites of tissue injury or microbial colonization [5, 24] . Thus, platelets respond rapidly and are numerically abnormal valves); (2) expression of agonists and/or ligands that promote platelet deposition and platelet-fibrin matrix formation significant at sites of endothelial damage due to trauma or microbial colonization.
[3, 5, 38, 39] ; and (3) further deposition of circulating platelets Platelet factor-4 P-selectin PDGF C 3a 12-HETE C 5a TGF-a TGF-b NOTE. C Å complement protein; GP Å glycoprotein; PAF Å platelet activating factor; PDGF Å platelet-derived growth factor; PMP Å platelet microbicidal protein; tPMP Å thrombin-induced PMP; TGF Å transforming growth factor; vWF Å von Willebrand factor. in response to agonists (e.g., TXA 2 , ADP, and PAF), or ligands traditional interpretation of the role of platelets in these settings (e.g., GPIIb-IIIa) associated with platelet activation (figure 2) [14] .
has been that they promote the establishment and evolution of Pathogens considered to be less virulent than staphylococci, endovascular infection [25 -28, 32, 40] . Work by several such as viridans streptococci, are believed to require altered or groups has suggested that platelets facilitate microbial adhesion damaged vascular endothelium to initiate endovascular infection.
to fibrin matrices or endothelial cells in vitro [25, 27, 41] . Pathways likely involve indirect adherence to intact or abnormal Recent studies have demonstrated that both bacterial and fungal vascular endothelium [5, 20, 21, 29] , vascular endothelial cell pathogens can aggregate human and rabbit platelets in vitro expression of platelet ligands and agonists (see above), and further [42 -45] . Herzberg et al. [46] have suggested that streptococci platelet-fibrin deposition and evolution of the lesion ( figure 2) that vigorously bind to and aggregate platelets may have in- [29] [30] [31] [32] [33] [34] [35] . Regardless of the specific pathway, platelets are among creased virulence in experimental models of endocarditis. the most rapid and abundant inflammatory components that rePlatelets and microorganisms have been found to interact spond to damage or colonization of endothelium. From this perthrough specific ligands ( [43, 44] outlined below), suggesting spective, platelets may be viewed as the earliest of opportunities pathogens may exploit platelets as adhesive sites via molecular for inflammatory response to intercede in antimicrobial host demimicry. It has also been argued that platelet aggregation is fense against induction and evolution of endovascular infection.
detrimental to the host, since massive endovascular vegetations are often associated with clinical complications such as emboli Previous Studies Have Been Interpreted To Suggest that and infarcts [32, 47] . Some investigators contend that platelet Platelets Facilitate Infection aggregation and internalization of microorganisms may protect pathogens from exposure to antibiotics or clearance by neutroAs outlined above, it is clear that platelets are present in the setting of infections involving the vascular endothelium. The phils or other leukocytes [3, 48] . [3, bers are significantly depleted within 3 days after infection of mice with Friend leukemia virus. Likewise, Oski and Naiman 53, 57]. In this regard, platelets exhibit positive chemotactic responses to stimuli present in the setting of infection. Platelets [74] reported that human megakaryocyte counts reach a nadir 3 days after vaccination with live measles vaccine. In each are capable of interacting directly and indirectly with a broad variety of microbial pathogens both in vitro and in vivo (see case, primary thrombocytopenia was observed roughly 3 -5 days after initial viral challenge. On the basis of findings such below). Platelets can internalize microorganisms into phagosome-like vacuoles, enhancing pathogen clearance from the as these, primary thrombocytopenia that is associated with acute viral infection has been interpreted as resulting from bloodstream [49, 58, 59 ].
Platelets stimulated with certain agonists or microorganisms direct viral injury of megakaryocytes or platelets rather than from secondary immune clearance of infected cells. are capable of generating oxidative molecules and free radicals such as superoxide anion, hydrogen peroxide, hydroxyl radical, Myxoviral neuraminidase has been demonstrated to reduce platelet lifespan by cleaving sialic acid in the platelet membrane singlet oxygen, and lipoperoxides [60, 61] . Thus, platelets respond to these stimuli by producing cytotoxic oxygen metabo- [69, 70] . Newcastle disease virus also appears to disrupt the platelet membrane, leading to lysis [70, 75] . Ultrastructural lites. Similar to neutrophils and macrophages, granules within activated platelets are mobilized by microtubule assembly and studies of megakaryocytes and platelets from patients with AIDS show that HIV damages the nuclei of the former cells are subsequently secreted (see above). In the presence of IgE, platelets exhibit cytotoxic capabilities against microfilariae, and and the intracytoplasmic structures of the latter cells [63, 64, 72] . Alternatively, viruses that do not reproduce in the megain the presence of C-reactive protein, they exhibit cytotoxic capabilities against Schistosoma [50, 51, 62]; outlined below).
karyocyte, such as human parvovirus 19, may indirectly interfere with the production of normal platelets and produce thromNumerous investigators have reported that platelets inhibit growth of bacterial pathogens or kill these organisms (see bebocytopenia [76] . Such viruses, absorbed onto or internalized within platelets, may prompt aggregation and degranulation, low). Taken together, these studies provide substantive evidence supporting the likelihood that platelets possess explicit facilitating a subsequent coagulation cascade and further depletion of platelets. antimicrobial function.
Immune thrombocytopenia (ITP) may also result from viral infection. Unlike virus-mediated primary thrombocytopenia, which generally occurs within 5 days of infection, viral-induced Platelets Interact Directly and Indirectly with Most ITP typically evolves 7 -10 days after the primary symptoms Microorganisms of the infection have manifested. Thus, in most instances, the onset of ITP is observed within 14 -20 days after initial viral Platelets interact with viruses. There is considerable evidence that viruses interact with and are internalized by megainfection. 71, 72] . Although platelets lack significant macromolecular biosynthesis, several studies have demonstrated viVirus-infected megakaryocytes and platelets accumulate in the spleen and bone marrow [68] . Viral antigens, as well as ral budding from platelet internal membranes [65, 66] . Following entry, viral antigens gradually appear on the surface excessive levels of platelet surface-associated IgG, are believed to mediate platelet destruction at these sites via the of the host platelet. For example, influenza virus hemaggluti-
10-23-97 10:06:15 cida UC: CID reticuloendothelial system. In addition, platelets with unusuthrough irreversible aggregation phases. For instance, S. aureus and S. pyogenes have been shown to be nearly equivalent in ally high levels of bound IgG may be subject to destruction by the classic complement pathway, and they have been shown to their rapid and complete induction of platelet aggregation, while E. coli and E. faecalis cause platelets to aggregate much be destroyed by virus activation of the alternative pathway [80] . Striking examples of profound ITP resulting from imless rapidly and vigorously [48, 82] . Several factors appear to influence the capability of bacteria mune-mediated platelet damage and of thrombocytopenia from direct platelet and megakaryocyte injury include those to activate platelets. Herzberg et al. [92, 93] made the observation that viridans streptococci could bind directly to the platelet observed in hemorrhagic viral infections such as dengue fever or hantavirus infection [81] .
surface in a manner that was reduced by exposing the organisms to proteases. Sullam et al. [94] have recently used flow Although platelets certainly interact with viruses, the consequences of platelet-viral interaction from the perspective of cytometry to study the interaction of Streptococcus species with rabbit and human platelets in vitro. Similarly, Bayer et host defense remain unclear. It is accepted that viruses may enter and reproduce within platelets and megakaryocytes (see al.
[95] and Yeaman et al. [96] have recently examined the molecular basis for the interaction between S. aureus and rabbit above). Viral antigens subsequently appear on the surfaces of these cells. However, whether platelet internalization of viruses platelets by using aggregometry complemented with flow cytometry. These investigators have shown that these pathogens and expression of viral antigens on platelet surfaces serve to reduce viremia, enhance clearance of infected platelets or are capable of binding directly to washed human or rabbit platelets in vitro. megakaryocytes, or exert direct antiviral activities has not been clearly established to date.
The bacterium-to-platelet ratio has a direct relationship on the velocity and extent with which platelet aggregation occurs Platelets interact with bacteria directly and through a variety of mediator ligands. The fact that mammalian platelets [95, 96] . In addition, bacteria rapidly adhere to platelets in a manner that is both saturable and reversible [94 -96] , suginteract directly and indirectly with bacterial pathogens has been well established both in vitro and in vivo. Perhaps the gesting the initial contact between these cells occurs via receptor-ligand interactions. However, the possibilities that bacteria most extensive studies performed on this topic are those of Clawson and White [48], Clawson [83] , and Clawson et al.
and platelets may interact though multiple ligands or by nonspecific interactions such as charge or hydrophobicity have not [84] . In this series of studies, a variety of bacterial pathogens were shown to be capable of binding to, aggregating, and inducbeen ruled out. It is evident that different bacterial species and strains have ing secretory responses of platelets. The sequence of events in platelet-bacterial interaction proceed through four distinct different mechanisms by which they interact with platelets. Along with their ability to directly bind platelets, staphylococci phases: contact, shape change, early aggregation, and irreversible aggregation [82] . Over the course of this process, platelets and streptococci appear to rely on plasma cofactors to facilitate their interplay with platelets. For example, staphylococci use that physically interact with bacterial cells change from smooth discoid cells to amoeboid cells with pleiomorphic pseudopodia fibrinogen bridging as a means of adhering to endothelial cells and platelets [97, 98] . In contrast, fibronectin does not appear [83] [103] , and it has been suggested that this activation leads to thrombocytopenia, comaggregation [82] . Other investigators have shown that an even more diverse group of bacterial pathogens may interact with plement activation, and disseminated intravascular coagulation. Furthermore, lipopolysaccharide rich in lipid A amplifies the and aggregate platelets in vitro, including species of Fusobacterium [85] , Listeria [86] , Mycobacterium [87] , Pseudomonas interaction among platelets, IgG, microorganisms, and immune complexes [104] . This fact may contribute to the observation [88] , Salmonella [89, 90] [114] have demonstrated that platelets inhibit or kill vivax [126] . The interaction of platelets with these microorganisms apa variety of bacterial pathogens in vitro, including Bacillus, Staphylococcus, and Salmonella. Czuprynski and Balish [86] pears to require IgE and the platelet surface IgE receptor. Studies with radiolabeled IgE have shown that platelets, which found that rat platelets exhibit inhibitory action against Listeria monocytogenes in vitro. The specific mechanisms by which possess approximately 1,000 high-affinity IgE receptors, interact with protozoa specifically through this receptor [127] . In platelet-bacterial interactions may result in antibacterial effects are outlined below. In addition to these direct antibacterial addition, IgE-rich sera obtained from patients infected with S. mansoni stimulate platelets to exert cytotoxic activities effects, platelets also appear to augment the antibacterial activities of neutrophils, monocytes, and macrophages (see platelet against this organism [50] . Related studies have shown that immune serum or IgE monoclonal antibody can prompt cytointeraction with leukocytes, below).
Platelets interact with pathogenic fungi. The interaction toxic activities of platelets from uninfected animals against S. mansoni [128] . The observation that immune serum alone between mammalian platelets and pathogenic fungi remains an area which deserves greater attention. This is particularly true does not cause protozoal killing underscores the fact that platelets are effector cells integral to antiprotozoal activity [3, 128] . in light of the emergence of fungi such as Candida albicans as among the most common bloodstream isolates recovered in Thus, it is apparent that platelets contribute to antimicrobial host defense against protozoal infection via mechanisms that the nosocomial setting [115 -118] . The fact that many pathogenic fungi enter the intravascular compartment also suggests include antibody-dependent cell cytotoxicity (see below). Related investigations have revealed that TNF-a and TNFthat interaction with platelets may influence their potential for pathogenesis.
b, as well as INF-g, enhance platelet-mediated protozoal killing [54, 129] . Alternatively, platelet activity suppressive lymSeveral fungal organisms have recently been shown to adhere to and aggregate mammalian platelets. For example, phokine is released from mitogen-stimulated T lymphocytes (CD4 0 and CD8 / lymphocytes). This molecule reduces the Maisch and Calderone [40, 119] demonstrated that C. albicans and Candida stellatoidea adhere to and aggregate platelets and IgE-dependent cytotoxic activities of platelets [130] . On balance, these investigations demonstrate that platelet functions platelet-fibrin matrices in vitro. C. albicans also binds to these matrices in the animal model of infective endocarditis [27] . related to antiprotozoal host defense are modulated by diverse cytokines that may be present in the setting of infection. Robert et al. [44] of blood. Hirsch [133] later reported that platelets, not other leukocytes, reconstitute the bactericidal activity of platelet-free rabbit serum. purify five PMPs from acid-extracted rabbit platelets (PMPs 1 -Since these initial observations were made, numerous in-5) and two thrombin-induced PMPs from thrombin-stimulated vestigators have worked to isolate and characterize the platerabbit platelets (tPMPs 1 and 2; table 2) [147] . PMPs 1 -5 are let-specific molecule(s) associated with the antimicrobial acnot substantially released by thrombin-stimulated platelets, and tion of serum [134 -141] . In early studies, Myrvik [137] tPMPs are not found in platelet acid extracts [147] . In addition, concluded that two platelet-derived components in serum Azizi et al. [148] and Ramos et al. [149] have demonstrated were associated with the killing of Bacillus subtilis. Jago and that microorganisms or purified staphylococcal a-toxin prompt Jacox [111] , as well as Myrvik and Leake [138] , supported the release of PMPs and tPMPs from rabbit platelets in vitro. this finding by independently isolating two heat-stable proThese findings suggest that PMPs may be differentially released teins, which correspond with serum bactericidal action, from from platelets in response to tissue trauma, soluble mediators rabbit and rat platelets. Johnson and Donaldson [139] and of inflammation, or microorganisms. Donaldson and Tew [140] isolated distinct b-lysins from rabStudies with use of mass spectroscopy have shown that bit serum that were specific in their killing of either S. aureus known PMPs and tPMPs range in size from 6.0 kD to 9.0 kD or B. subtilis. Similarly, Weksler and Nachman [141] isolated (table 2) [147] . Compositional analyses reveal that PMPs and two platelet cationic proteins with molecular masses of 10 tPMPs are cationic, containing high ratios of the basic amino kD and 40 kD that were bactericidal in vitro against B. subtilis acids lysine, arginine, and histidine (total content, Ç25%). and S. aureus strains.
Antimicrobial Functions of Platelets
PMP and tPMP antimicrobial activities are heat stable [146, Each of these molecules was shown to be cationic and 147], and anionic adsorption neutralizes these activities [146, small, with molecular masses ranging from Ç6 -40 kD. Tew 147, 150] . Differences in molecular mass and a conspicuous et al. [142] demonstrated that one or more b-lysin molecules presence of lysine differentiate PMPs from neutrophil defenwere released from rabbit platelets stimulated with thrombin.
sins [147, 151] . In addition, PMPs and tPMPs have been In a series of studies, Carroll and Martinez [134 -136] dedistinguished from platelet lysozyme on the basis of mass, scribed the isolation, microcompositional analysis, microbiciamino acid composition, and antimicrobial activity [146, 147] . dal spectrum, and possible mechanisms of action of an antiStudies of performic acid -oxidized PMPs and tPMPs have bacterial peptide (PC-III) from rabbit serum. Darveau et al. revealed significant differences among their cystine composi- [143] identified peptides related to platelet factor-4 that had tions. For instance, PMPs 1 -3 each have four cystine resiantimicrobial capacity. Dankert [144] and Dankert et al. [145] dues, while PMPs 4 and 5 have three; these cystine residues have also suggested that rabbit platelets release platelet-assodiffer from those of tPMPs 1 or 2, which have two or fewer ciated bactericidal substances following stimulation with cystine residues [147] . thrombin.
The above findings suggest that there are important strucYeaman et al. [146, 147] have recently isolated and charactural differences among PMPs and tPMPs. These differences terized proteins that likely contribute substantially to the antimay be relevant to their microbicidal activities or possible microbial effects of platelets. Platelet microbicidal proteins abilities to potentiate neutrophil antimicrobial functions (see (PMPs [146] ) have been found in supernatants of rabbit platebelow). Thus far, tPMP-1 has been isolated exclusively from lets exposed to acid extraction or thrombin stimulation [147] .
supernatants of thrombin-induced platelets. As previously The fact that thrombin is a potent platelet agonist generated in noted, S. aureus cells or a-toxin elicit the release of PMPs the setting of endovascular infection may be relevant to PMP 1 -3 in vitro [148, 149] . These findings suggest that specific release in this situation [19 -21] . Reversed-phase high perforplatelet stimuli prompt the release of specific PMPs. For example, thrombin activation of platelets could induce the promance liquid chromatography has been used to homogeneously / 9c3f$$no84 10-23-97 10:06:15 cida UC: CID cessing of one or more tPMP precursors, yielding active of defensins [157, 158] . In comparison, studies to date indicate PMPs 1 -5 each contain 3 -4 cystine residues, similar to defentPMP-1 or tPMP-2. Initial structural characterizations indicate a low likelihood that PMPs 1 -5 serve as putative precursors sins [147] . However, tPMP-1 appear to contain few or no cystine residues, more closely resembling magainins or cecropins [147] . This finding would further suggest that the tPMP precursors are inactive. Thus, the possibility exists that thrombin, (table 2) [147] . Studies are ongoing to more completely characterize the structures of PMPs and tPMPs. a serine protease, directly cleaves or indirectly activates other platelet proteases to cleave hypothetical tPMP precursor(s), yielding secreted tPMPs.
PMPs Exert Potent and Broad-Spectrum Antimicrobial Tang et. al. [152, 153] recently isolated and identified microActivities In Vitro bicidal peptides from human platelets; these peptides appear structurally and functionally analogous to rabbit PMPs. Like Purified PMPs 1 -5 and tPMPs 1 -2 exert potent microbicidal activities in vitro against a broad spectrum of bacterial and rabbit PMPs, these human peptides exert potent and synergistic microbicidal activities in vitro against B. subtilis, S. aureus, fungal pathogens. These pathogens include B. subtilis, S. aureus and S. epidermidis, viridans group streptococci, E. coli, and C. albicans ( [152, 153] ; see below). These data provide evidence that the existence of antimicrobial peptides E. coli, Candida albicans, and Cryptococcus neoformans [146, 147, 150] . The microbicidal effects of PMPs and tPMPs are is conserved among mammalian platelets. Furthermore, the structural and functional similarities between rabbit and human achieved in submicromolar concentrations (1 -5 mg/mL; [147] ). In addition, these peptides are active against microbial pathoPMPs may provide future opportunities to use various rabbit models (e.g., of infective endocarditis) to investigate the role gens in physiological ranges of pH (5.5 to 8.0) and in plasma or serum [160] . Thus, the antimicrobial activities of PMPs and of human platelets and PMPs in antimicrobial host defense. Investigations to more thoroughly characterize the structures tPMPs observed in vitro are relevant to conditions that exist in vivo within the vascular compartment or adjacent tissues. of microbicidal peptides from rabbit and human platelets are under way.
PMPs Appear To Target and Disrupt Microbial Cytoplasmic Membranes PMPs Differ from Other Endogenous Antimicrobial Peptides in Structure
The morphologic consequences of exposing rabbit PMP-2 and tPMP-1 to bacterial cells, protoplasts, and lipid bilayers in Structural data obtained to date suggest that PMPs and tPMPs differ from other endogenous antimicrobial peptides.
vitro have been investigated by using transmission electron microscopy and biophysical techniques [154 -156, 161] . These However, some similarities between PMPs and other analogous peptides include low mass (£10 kD [147] ); composition rich studies reveal rapid cytoplasmic membrane disruption, followed by cell-wall thickening in S. aureus after exposure to 10 in basic amino acids, accounting for cationic charge [147] ; broad antimicrobial spectra in vitro (e.g., coverage of bacteria mg/mL of tPMP-1 for 15 -60 minutes. Ultrastructural damage precedes detectable bactericidal and bacteriolytic effects [156] . and fungi [146, 147, 150] ); potent microbicidal activity in nanomolar concentrations [147] ; and perturbation of the microbial Fungal pathogens are likewise damaged by tPMP-1 in vitro [150] . Protoplasts prepared from S. aureus whole cells exhibit cytoplasmic membranes as a mechanism of action ( [154 -156] ; see below). similar damage, indicating membrane damage is not dependent on the presence of the cell wall [162] . Koo et al. [162] demonIn contrast, PMPs and tPMPs have several characteristics that distinguish them from other antimicrobial peptides. For strated that tPMP-1 appears to produce these effects via a mechanism that involves voltage-dependent membrane permeabiliexample, PMPs and tPMPs differ in size from other endogenous antimicrobial peptides. Defensins exist in their native zation. These temporal and ultrastructural findings suggest that one primary target of action for these peptides is the microbial forms as 29 -34 amino-acid peptides, with masses of Ç3-4 kD [151] . Similarly, amphibian magainins and insect cecropins cytoplasmic membrane. range in mass from 2.5 kD to 4.5 kD [157, 158] . PMPs and tPMPs are larger, with molecular masses ranging from Ç6.0 PMP Mechanisms of Action May Differ from Those of kD to 9.0 kD (Ç70 -100 amino acids [147] ). Furthermore, Other Antimicrobial Peptides neutrophil defensins have three invariant pairs of cystine residues that mediate disulfide bridging [151] .
Many antimicrobial peptides appear to target and disrupt the microbial cytoplasmic membrane. In this regard, PMPs are These intramolecular bridges stabilize three domains in defensins, conferring their characteristic amphiphilic, helical conlikely similar to other antimicrobial peptides. However, PMPs exhibit significant differences from other microbicidal peptides figurations [151] . In contrast, nonmammalian magainins and cecropins do not exhibit cystine-mediated secondary structure in several key ways, which may be relevant to their antimicrobial host defense functions. As outlined above, the mass and [157 -159] . However, primary structures of these molecules induce amphiphilic a-helical motifs that are analogous to those composition of PMPs differ from those of other endogenous / 9c3f$$no84 10-23-97 10:06:15 cida UC: CID Yeaman CID 1997; 25 (November) antimicrobial peptides. Furthermore, PMPs may be unique tPMP-1 may be independent from other platelet-microorganism interactions. among these peptides because they are released into the bloodstream as a result of normal platelet response to agonists generAs described above, S. aureus adhesion to platelets in vitro is rapid, saturable, and reversible, a finding that suggests a ated in the setting of infection. In addition, the mechanisms of action of PMPs against PMP-susceptible (PMP S ) and PMPreceptor-ligand interaction. Modified Scatchard analyses indicate that the number of binding sites per platelet vary among resistant (PMP R ) S. aureus appear to differ from that of human defensin NP-1(hNP-1) [154, 155] . For example, the staphyloci-S. aureus strains [96] . This observation further suggests that platelet binding by these organisms is specific. Furthermore, dal activities of PMP-2 and tPMP-1 are related to the baseline transmembrane potential (DC) of the target cell [155] . In conthe binding of individual S. aureus cells to platelets appears to be influenced more by the number of binding sites on platelets trast, hNP-1 exerts staphylocidal activities that are not influenced by baseline DC among the organisms studied [154] .
than on platelet binding affinities of bacterial cells [96] . Proteolytic treatments do not appear to alter the binding of S. aureus Furthermore, PMP-2 and tPMP-1 cause staphylococcal cell death by mechanisms that differentially involve membrane deto rabbit platelets. However, exposure to tPMP-1 or periodate significantly reduces platelet staphylococcal adherence to rabbit polarization. These observations suggest that distinct PMPs, tPMPs, and defensin hNP-1 may employ different mechanisms platelets [96, 166] . These findings suggest that S. aureus adhesion to platelets is multimodal, involving both tPMP-1 sensitive of action, which may reflect their structural and functional differences. However, the precise mechanisms of PMP action, and carbohydrate surface ligands. Complementary studies have demonstrated that in vitro exposure to tPMP-1, alone or with as well as whether PMP and tPMP mechanisms are similar to those of other antimicrobial peptides, remain to be determined.
antibiotics, significantly reduces the adhesion of tPMP S or tPMP R S. aureus strains to platelets in vitro [166] . This phenomenon is observed despite the fact that antibiotics alone PMPs Potentiate the Antimicrobial Actions of (ampicillin, sulbactam, or their combination) increase bacterial Conventional Antibiotics adhesion to platelets in vitro [166] . In addition to the anti-adhesive functions of PMPs, tPMP-1 Platelet products are known to interact with conventional antibiotics. For example, Asensi and Fierer [163] demonstrated interferes with aggregation of platelets by staphylococci in vitro [167] . Exposure of tPMP S or tPMP R S. aureus strains to sublethat b-lysin and ampicillin interact synergistically in vitro to inhibit L. monocytogenes. PMPs also potentiate conventional thal concentrations of tPMP-1 reduces both the velocity and magnitude of S. aureus -induced platelet aggregation [167] . antibiotics against S. aureus. For example, tPMP-1, in combination with antistaphylococcal antibiotics, exerts potent synerThese findings indicate that the mechanism of platelet aggregation by S. aureus is sensitive to modulation by tPMP-1. gistic bactericidal effects against inocula representing bacterial densities within early, developing, and established endocarditis Whether tPMP-1 achieves this effect by altering the bacteriumto-platelet binding, or by other mechanisms, has not been detervegetations in vitro, regardless of whether strains are intrinsically tPMP S or tPMP R [164] . In addition, sublethal exposures mined. Nonetheless, it is conceivable that PMPs and tPMPs also exert anti-adhesion or anti-aggregation effects that funcof tPMP-1 exert prolonged growth inhibitory effects similar to those described for vancomycin and oxacillin [164] . Sequential tion in host defense. exposure of S. aureus to tPMP-1, followed by exposure to these antibiotics, amplifies the postexposure growth inhibitory period, as compared with either agent alone [164] .
Platelets Modulate Complement Activation
A variety of studies have shown that platelets interact with PMPs Modulate Microorganism-Platelet Interactions components of the complement system to amplify or suppress complement fixation. For instance, human platelets are capable Distinct interaction parameters among human bacteremic S. aureus isolates and platelets have recently been examined.
of mediating the generation of the C 5 -C 9 complex [168 -170] . Platelet surface complement receptors subsequently bind to These include platelet adhesion, platelet aggregation, and susceptibility to tPMP-1 [96, 165] . For each of these interactions, microorganisms exhibiting this complex. Platelet proteases cleave C 5 to C 5a , thereby providing a positive chemotactic stimheterogeneities among S. aureus clinical isolates exist. However, a significant positive correlation between platelet adherulus for recruitment of neutrophils and macrophages [171] . Complement stimulation of platelets induces platelet activation, ence and aggregation has been noted among these strains. In contrast, there was no correlation between either platelet adherphospholipase activity, and degranulation [169, 172] . Prostaglandin synthesis and release by platelets is triggered by comence or aggregation and in vitro susceptibility to tPMP-1 [165] . These data confirm the previous findings of Clawson and White plement proteins C 5 -C 9 [168] . Furthermore, platelet generation and release of free radicals have been linked to stimulation by [48, 82] , Clawson [83] , and Clawson et al. [84] , suggesting that S. aureus platelet adhesion and aggregation are linked.
C-reactive protein [173] , C 3b and C 5 -C Zucker et al. [177] have demonstrated that deficiencies of platelets facilitate phagocytosis of Salmonella by mouse peritoneal macrophages. PF-4 amplifies neutrophil fungicidal activity complement protein C 3 , C 5 , C 6 , or C 7 are associated with subdued platelet activities in patients. Complement alternative in vitro [182, 184] . Serotonin released from platelet-dense granules increases the adherence of neutrophils to vascular endothepathway factor D exists within platelet a-granules and is believed to be released from thrombin-stimulated platelets [178] .
lial cells in vitro [194] . Platelet TXA 2 has also been shown to enhance neutrophil adhesive properties [195] . MonocyteThus, platelet activation may be integrally linked to activation of the alternative pathway of complement fixation. On balance, derived IL-6 has likewise been shown to induce cytotoxicity of human platelets to S. mansoni larvae in vitro [54] . Most platelets may also down-modulate complement activation. For example, platelet-decay-accelerating factor suppresses C 3 conrecently, Christin et al. have demonstrated that platelets and neutrophils act synergistically in the in vitro damage and killing vertase activity of the C 4b2a complex in classic complement fixation [179] . Similarly, platelet factor H may negatively reguof Aspergillus fumigatus [120] . Taken together, these findings underscore the likelihood that platelet interactions with leukolate alternative pathway complement fixation [178] .
cytes are likely integral to host defense against infection.
Platelets Augment the Antimicrobial Functions of Leukocytes Recent Evidence Indicates Platelets and PMPs Act in Host Defense Against Infection In Vivo
The interaction of platelets with monocytes and neutrophils likely provides an additional mechanism by which platelets
Evidence from in vivo studies that supports an antimicrobial host defense role for platelets is also accumulating. Wu et participate in antimicrobial host defense. A variety of molecules released from activated platelets are positive chemotacal. [196] examined the relationship between staphylococcal susceptibility to tPMP-1 in vitro and the clinical source of tic stimuli for monocytes and neutrophils. These molecules include platelet factor 4 (PF-4), platelet activating factor bacteremic isolates. For S. aureus and S. epidermidis isolates, a significant correlation exists between the source of infective (PAF), platelet-derived growth factor (PDGF), and eicosanoids such as 12-HETE [178 -185] . Subcutaneous injection endocarditis and in vitro survival following exposure to tPMP-1 (i.e., tPMP-1 resistance). These data suggest that tPMP S orof PF-4 and PDGF rapidly induces neutrophil infiltration in experimental animals [186] . [197, 198] . strated that thrombin-activated platelets bind to human monocytes and neutrophils, while unactivated platelets do not. The Thrombocytopenia has been shown to be a significant independent indicator of higher morbidity and mortality among apparent mechanism for this interaction is receptor-mediated affinity to thrombospondin released from, and rebound to, the patients undergoing cytotoxic cancer chemotherapy [199] . In the absence of neutropenia, thrombocytopenia has also been platelet surface [189] . In addition, the GPIIb-IIIa receptor expressed by activated platelets may also facilitate monocyte positively correlated with an increased incidence and severity of lobar pneumonia in elderly individuals [200] . In addition, use and neutrophil adhesion to tissues [190] .
Alternatively, molecules generated by activated monocytes of antiplatelet agents in the experimental endocarditis model significantly increases levels of bacteremia and mortality [201, or neutrophils may activate platelets. For example, oxygen metabolites, myeloperoxidase, and halides produced by neutro -202] . Moreover, Berney and Francioli [203] and Yersin et al. [204] demonstrated that neutropenia in the setting of a normal phils are capable of prompting platelet degranulation [3, 60, 191] . PAF released by neutrophils and monocytes has a proplatelet count does not diminish host defense against endovascular infection in vivo. found stimulatory effect on platelets. This agonist triggers a change in platelet shape, expression of inducible receptors (e.g.,
The majority of extant data suggest that the platelet-microbe interaction attenuates infection in vivo. Other reports have conGPIIb-IIIa), and granule organization consistent with platelet activation [3, 14] . In combination with subactivational levels tradicted this line of evidence, suggesting that antiplatelet therapies may worsen the course of endovascular infection. For of epinephrine or thrombin, neutrophil leukotrienes C4, D4, or E4 amplify platelet aggregation and degranulation [192] .
example, Nicolau et al. [205] found that aspirin administered prophylactically reduces the severity of infective endocarditis Moreover, monocytes exposed to bacterial components generate tissue factor, which elicits thrombin production and subsedue to S. aureus in the rabbit model. In these studies, platelets were believed to suppress the induction phase of endovascular quent platelet activation [19, 193] . Thus, an interplay exists between leukocyte and platelet activation.
infection. However, given that aspirin is a global inhibitor of cyclooxygenase function (e.g., endothelial cells as well as In addition to recruiting monocytes and neutrophils to sites of infection, platelet activation has been linked to potentiation platelets), these findings remain difficult to interpret. Moreover, / 9c3f$$no84 10-23-97 10:06:15 cida UC: CID it is possible that antiplatelet agents exacerbate later evolutionsimilarities and differences between rabbit and human platelets [209] may be examined in this model to facilitate evaluation ary stages in endovascular infection. Nonetheless, platelet inhibitors that reduce aggregation but do not diminish degranulaof the role of PMPs in endovascular and other infections. The advent of increasingly specific platelet inhibitors will tion could conceivably enhance PMP, tPMP, or cell-mediated immune antimicrobial activities in vegetations or thrombi of further enhance the experimental value of this model. These future studies may provide important insights regarding PMP reduced density, surface area, or mass. These possibilities require further investigation.
and platelet functions in human infections. In addition, results from these investigations could lead to new therapeutic interAntimicrobial host-defense roles for platelets and PMPs have recently been demonstrated in vivo by using two complemenventions in human infections. For example, thrombopoietin could potentially be used to stimulate platelet-mediated host tary approaches. Sullam et al. [202] examined the role of platelets in defense against infective endocarditis in vivo. In this defense in neutropenic patients. The fact that PMPs and tPMPs synergistically interact with antimicrobial agents could be exstudy, a tPMP S viridans streptococcal strain was used to induce endocarditis in experimental animals either with normal platelet plored to improve the efficacies of conventional antibiotics. Alternatively, PMPs and tPMPs may provide templates for counts or with selective immune thrombocytopenia. Thrombocytopenic animals had significantly higher streptococcal densithe development of novel antimicrobial agents that act against pathogens exhibiting multiple antibiotic resistance. ties in vegetations than did their counterparts with normal platelet counts [202] . Data from Dankert [144] and Dankert et al.
Novel approaches will also provide important new information regarding the role of platelets in antimicrobial host defense. [145] also support the concept that platelet-derived molecules are active in host defense against infective endocarditis. These For example, platelets may possess other antimicrobial components that augment their host defense functions. Recent studies data indicate that platelets and PMPs are important in limiting the induction and evolution of endovascular infection.
have revealed that phospholipase activity, similar to that resulting from platelet activation, is associated with potent antiEvidence also exists substantiating the likelihood that PMPs participate in the observed antimicrobial function of platelets staphylococal activity of inflammatory fluid [169, 172, 210] . Alternatively, microorganism strain pairs that differ in platelet in vivo. Yeaman et al. [206] have demonstrated that susceptibility to tPMP-1 negatively influences the establishment and evoadherence, aggregation, and susceptibility to PMPs and tPMPs are currently being developed and evaluated. To date, S. aureus, lution of C. albicans infection. In the rabbit model, tPMP S C. albicans exhibits significantly less proliferation in cardiac viridans streptococci, and C. albicans strains have been examined in this regard (see above). These strain pairs, and those vegetations than does a related tPMP R strain [206] . In addition, the incidence of splenic dissemination of tPMP S C. albicans yet to be identified, will facilitate future investigations into the mechanisms of action of PMPs and tPMPs and their roles, as is dramatically lower than that of the tPMP R strain. Similarly, Dhawan et al. [207] have found that in vitro phenotypic resiswell as those of platelets, in host defense against infection. Moreover, other studies will provide opportunities to examtance to tPMP-1 is correlated with enhanced virulence in animal models of endocarditis due to S. aureus. These studies suggest ine the significance of platelets in antimicrobial host defense. For example, large multicenter investigations examining novel that the host defense function of platelets may be due to elaboration of PMP(s) at sites of microbial colonization of vascular anticoagulation therapies (e.g., anti-GPIIb-IIIa antibody), new cytotoxic chemotherapeutic agents, regimens that differentially endothelium. Alternatively, diminished platelet binding in vitro has been shown to correlate with reduced virulence of an S.
induce thrombocytopenia and neutropenia (e.g., carboplatinum derivatives), or the pathogenesis of atherosclerosis may create aureus strain in the rabbit model of infective endocardits [208] . This finding illustrates the concept that certain organisms may new opportunities and databases for examining the antimicrobial and host defense functions of human platelets. be capable of using the platelet as an adhesive surface. Presumably, pathogens such as these are capable of circumventing the antimicrobial properties of platelets.
Summary Future Studies Will Provide New Insights into Platelet
Mammalian platelets are specialized inflammatory cells. In Roles in Antimicrobial Host Defense this capacity, they exhibit features characteristic of classic cell-mediated immune effector cells. It is well established that Overall, the above findings provide direct evidence that platelets and PMPs play a key role in host defense in the setting platelets contain and can be stimulated to release a variety of bioactive molecules that contribute to regulation of vascular of endovascular infections such as infective endocarditis. In addition, these observations suggest that the antimicrobial actone, increased tissue adhesiveness, enhancement of vascular permeability, facilitation of clot dissolution, and promotion tivities of platelets may be demonstrable at sites remote from the heart. These findings further emphasize the importance of of wound healing and tissue regeneration. These functions have traditionally been associated with platelets as cells that studying models such as the rabbit to investigate analogous platelet host defense mechanisms in humans. For example, the maintain hemostasis. 
